Neurocrine Biosciences Statistics
Total Valuation
NBIX has a market cap or net worth of $15.51 billion. The enterprise value is $14.87 billion.
| Market Cap | 15.51B |
| Enterprise Value | 14.87B |
Important Dates
The last earnings date was Tuesday, October 28, 2025, after market close.
| Earnings Date | Oct 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NBIX has 99.71 million shares outstanding. The number of shares has decreased by -1.30% in one year.
| Current Share Class | 99.71M |
| Shares Outstanding | 99.71M |
| Shares Change (YoY) | -1.30% |
| Shares Change (QoQ) | +1.49% |
| Owned by Insiders (%) | 1.09% |
| Owned by Institutions (%) | 99.94% |
| Float | 98.54M |
Valuation Ratios
The trailing PE ratio is 37.10 and the forward PE ratio is 17.39. NBIX's PEG ratio is 1.14.
| PE Ratio | 37.10 |
| Forward PE | 17.39 |
| PS Ratio | 5.76 |
| Forward PS | 4.61 |
| PB Ratio | 5.16 |
| P/TBV Ratio | 5.22 |
| P/FCF Ratio | 26.14 |
| P/OCF Ratio | 24.35 |
| PEG Ratio | 1.14 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 26.09, with an EV/FCF ratio of 25.07.
| EV / Earnings | 34.74 |
| EV / Sales | 5.54 |
| EV / EBITDA | 26.09 |
| EV / EBIT | 27.52 |
| EV / FCF | 25.07 |
Financial Position
The company has a current ratio of 3.38, with a Debt / Equity ratio of 0.16.
| Current Ratio | 3.38 |
| Quick Ratio | 2.89 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | 0.76 |
| Debt / FCF | 0.81 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 14.96% and return on invested capital (ROIC) is 10.41%.
| Return on Equity (ROE) | 14.96% |
| Return on Assets (ROA) | 8.66% |
| Return on Invested Capital (ROIC) | 10.41% |
| Return on Capital Employed (ROCE) | 14.89% |
| Revenue Per Employee | $1.49M |
| Profits Per Employee | $237,778 |
| Employee Count | 1,800 |
| Asset Turnover | 0.69 |
| Inventory Turnover | 17.15 |
Taxes
In the past 12 months, NBIX has paid $200.60 million in taxes.
| Income Tax | 200.60M |
| Effective Tax Rate | 31.91% |
Stock Price Statistics
The stock price has increased by +21.74% in the last 52 weeks. The beta is 0.27, so NBIX's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | +21.74% |
| 50-Day Moving Average | 143.53 |
| 200-Day Moving Average | 127.98 |
| Relative Strength Index (RSI) | 65.48 |
| Average Volume (20 Days) | 969,869 |
Short Selling Information
The latest short interest is 3.36 million, so 3.37% of the outstanding shares have been sold short.
| Short Interest | 3.36M |
| Short Previous Month | 4.11M |
| Short % of Shares Out | 3.37% |
| Short % of Float | 3.41% |
| Short Ratio (days to cover) | 3.15 |
Income Statement
In the last 12 months, NBIX had revenue of $2.68 billion and earned $428.00 million in profits. Earnings per share was $4.19.
| Revenue | 2.68B |
| Gross Profit | 1.70B |
| Operating Income | 540.30M |
| Pretax Income | 628.60M |
| Net Income | 428.00M |
| EBITDA | 570.00M |
| EBIT | 540.30M |
| Earnings Per Share (EPS) | $4.19 |
Balance Sheet
The company has $1.11 billion in cash and $479.70 million in debt, giving a net cash position of $635.10 million or $6.37 per share.
| Cash & Cash Equivalents | 1.11B |
| Total Debt | 479.70M |
| Net Cash | 635.10M |
| Net Cash Per Share | $6.37 |
| Equity (Book Value) | 3.00B |
| Book Value Per Share | 30.13 |
| Working Capital | 1.52B |
Cash Flow
In the last 12 months, operating cash flow was $636.80 million and capital expenditures -$43.70 million, giving a free cash flow of $593.10 million.
| Operating Cash Flow | 636.80M |
| Capital Expenditures | -43.70M |
| Free Cash Flow | 593.10M |
| FCF Per Share | $5.95 |
Margins
Gross margin is 63.21%, with operating and profit margins of 20.14% and 15.95%.
| Gross Margin | 63.21% |
| Operating Margin | 20.14% |
| Pretax Margin | 23.43% |
| Profit Margin | 15.95% |
| EBITDA Margin | 21.25% |
| EBIT Margin | 20.14% |
| FCF Margin | 22.11% |
Dividends & Yields
NBIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.30% |
| Shareholder Yield | 1.30% |
| Earnings Yield | 2.76% |
| FCF Yield | 3.83% |
Analyst Forecast
The average price target for NBIX is $173.79, which is 11.76% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $173.79 |
| Price Target Difference | 11.76% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 19 |
| Revenue Growth Forecast (5Y) | 12.48% |
| EPS Growth Forecast (5Y) | 31.60% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NBIX has an Altman Z-Score of 7.52 and a Piotroski F-Score of 4.
| Altman Z-Score | 7.52 |
| Piotroski F-Score | 4 |